CVKD   $14.88  6.21% Market Closed

Cadrenal Therapeutics Inc
Total Cash 5.04M
totalCashPerShare 4.72
EBITDA -6.63M
Total Debt 8.80K
quickRatio 3.439
currentRatio 3.716
Total Revenue
debtToEquity 0.22
Revenue/Share
ROA -0.91899
ROE -1.74013
grossProfits
freeCashflow -2.54M
operatingCashflow -4.69M
earningsGrowth
revenueGrowth
grossMargins 0.0
ebitdaMargins 0.0
operatingMargins 0.0
profitMargins 0.0
enterpriseValue 13.07M
forwardPE -3.728814
floatShares 664.38K
sharesOutstanding 1.50M
sharesShort 23.89K
sharesShortPriorMonth 19.35K
dateShortInterest
sharesPercentSharesOut 0.02%
heldPercentInsiders 0.38%
heldPercentInstitutions 0.02%
Short Ratio help_outline 0.52%
shortPercentOfFloat 0.03%
impliedSharesOutstanding
bookValue 3.741
Price To Book help_outline 4.70
earningsQuarterlyGrowth
netIncomeToCommon -6.24M
trailingEps -4.80%
forwardEps -4.72%
enterpriseToEbitda -1.97
lastDividendValue
lastDividendDate
currentQuarterEstimate -1.93 3Q 2024
institutionsCount 10
lastUpdated Nov. 2, 2024, 2:10 a.m.